When BiOxyDyn, (www.bioxydyn.com), a spin out company from Manchester University, needed to turn their innovative research and Intellectual Property (IP) in non-invasive medical imaging into a commercially robust, well-architected and fully-documented set of software tools, they called on Tessella’s unique blend of expertise in image analysis and scientific software engineering. The collaboration has enabled BiOxyDyn [...]

Tessella are proud sponsors of the GDDIS Summit 2011 taking place on November 7th – 8th at the prestigious Waldorf Astoria in Orlando, Florida, US. Meet Dr Andrew Chadwick, Principal Consultant for Life Sciences at Tessella and Grant Stephen, CEO of Tessella Inc at stand number 12. If you would like a prearranged meeting please email [...]

Focus group and survey confirm growing complexity of drug development and increasing adoption of smarter clinical trials Tom Parke, Head of Clinical Technologies, Tessella I was lucky enough to join a focus group at the recent 8th Annual SAS Health Care & Life Sciences Executive Conference (http://www.sas.com/news/preleases/hlsconf-clinicaltrials.html). The group comprising of selected pharmaceutical industry executives, [...]

Matthew Segall, Optibrium Ltd., Cambridge, U.K. and Andrew Chadwick, Tessella plc, Burton upon Trent, U.K. When human biases distort drug discovery decision-making, software tools can guide thinking towards objective answers…read more

Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions. The challenges of decision-making arise from the importance of multiple/conflicting criteria [...]

Tessella’s Head of Clinical Trials Solutions Tom Parke, will be speaking at the Perceptive User Group Meeting taking place on October 26-28, 2010 in Philadelphia, PA. Tom Parke be giving a talk on: What adaptive clinical trials promise What it takes to run an adaptive trial What can go wrong and how to prevent it, [...]

As pharma R&D leaders bring together their discovery and early development organizations they face tough decisions. How do you optimize project planning across a seamless R&D process? What is the right balance between risk, cost and value in the face of uncertainty? When and how should you deploy predictive technologies such as biomarkers? This webinar [...]

By Deborah Borfitz The first upgrade to a one-of-a-kind simulation tool co-developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical studies that can benefit from simulation of the design…read more

Tessella are corporate sponsors of ADAPT 2010, taking place on September 13-16th, 2010 at the Hyatt Regency Crystal City, Arlington, VA, USA. Tom Parke, head of clinical trial solutions at Tessella is a speaker at the event and will be giving a talk on Adpative Clinical Trials and Biomarkers and Scott Berry, President and Senior Statistical [...]

Tessella are sponsoring this year’s 2010 Accelrys European User Group Meeting, taking place at the Dolce Sitges Hotel in Barcelona, Spain on October 26-28th 2010. Mark Roberts from Tessella and Ed Ainscow from AstraZeneca will be speaking at the event.  The title of their abstract is ‘A Flexible Platform for Processing High-Content Screening Data’ which [...]